Carlos Trujillo's Net Worth
-$990 Thousand
Who is Carlos Trujillo?
Carlos Trujillo does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include VelaTel Global Communications, Inc., and PharmaCyte Biotech, Inc..
SEC CIK
Carlos Trujillo's CIK is 0001464520
Past Insider Trading and Trends
2012 was Carlos Trujillo's most active year for acquiring shares with 9 total transactions. Carlos Trujillo's most active month to acquire stocks was the month of June. 2012 was Carlos Trujillo's most active year for disposing of shares, totalling 30 transactions. Carlos Trujillo's most active month to dispose stocks was the month of May. 2009 saw Carlos Trujillo paying a total of $1,106,512.00 for 1,383,140 shares, this is the most they've acquired in one year. In 2009 Carlos Trujillo cashed out on 883,153 shares for a total of $706,522.40, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
VelaTel Global Communications, Inc. No price found
Chief Financial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +65,728.04% | 145M |
—
| $145,000.00 | 145.22M |
Aug 30 - Mar 24
| |||
Form 4
| -50.00% | -220.61K |
—
| -$220.61 | 220.61K |
Jan 14
| |||
Form 4
| -3.21% | -145.79K |
$0.08 | -$11,373.88 | 4.39M |
Dec 10 - Dec 13
| |||
Form 4
| +3,008.97% | 4.39M |
$0.03 | $133,968.54 | 4.54M |
Nov 21
| |||
Form 4
| -21.55% | -40.10K |
$0.03 | -$1,182.97 | 145.98K |
Oct 4 - Oct 5
| |||
Form 4
| -28.89% | -75.59K |
$0.03 | -$2,535.64 | 186.08K |
Sep 24 - Sep 26
| |||
Form 4
| -32.29% | -124.80K |
$0.05 | -$5,765.76 | 261.67K |
Sep 6
| |||
Form 4
| +1,064.91% | 353.3K |
$0.08 | $30,278.78 | 386.47K |
Aug 30
| |||
Form 4
| -26.61% | -12.03K |
$0.25 | -$3,007.00 | 33.18K |
Aug 7 - Aug 8
| |||
Form 4
|
∞
| 22.06M |
—
| $22,060.61 | 22.06M |
Jul 18
| |||
Form 4
| -30.67% | -2.00M |
$0.01 | -$16,335.00 | 4.52M |
Jul 11 - Jul 12
| |||
Form 4
| +56.06% | 2.34M |
$0.01 | $26,935.56 | 6.52M |
Jun 29
| |||
Form 4
| -19.54% | -1.01M |
$0.01 | -$11,777.00 | 4.18M |
Jun 12 - Jun 13
| |||
Form 4
| -10.67% | -620.00K |
$0.01 | -$7,273.00 | 5.19M |
Jun 11
| |||
Form 4
| -0.23% | -13.50K |
$0.02 | -$209.25 | 5.81M |
Jun 6
| |||
Form 4
| +83.98% | 2.66M |
$0.02 | $47,606.88 | 5.83M |
Jun 1
| |||
Form 4
| -2.53% | -82.05K |
$0.02 | -$1,501.46 | 3.17M |
May 23
| |||
Form 4
| +58.76% | 1.2M |
$0.02 | $26,938.40 | 3.25M |
May 2
| |||
Form 4
| -39.57% | -1.34M |
$0.02 | -$30,820.00 | 2.05M |
Apr 23
| |||
Form 4
| +136.48% | 1.95M |
$0.03 | $58,010.32 | 3.39M |
Apr 2 - Apr 3
| |||
Form 4
| -41.12% | -1.00M |
$0.03 | -$34,000.00 | 1.43M |
Mar 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 15
| |||
Form 4
| +183.60% | 1.57M |
$0.04 | $63,042.71 | 2.43M |
Feb 29 - Mar 5
| |||
Form 4
| +90.57% | 407.57K |
$0.55 | $222,124.02 | 857.57K |
Apr 8
| |||
Form 4
| -10.00% | -49.99K |
$1.20 | -$59,734.46 | 450K |
Feb 25
| |||
Form 4
| -63.85% | -883.15K |
$0.80 | -$706,522.40 | 499.99K |
Aug 11
| |||
Form 4
|
∞
| 1.38M |
$0.80 | $1,106,512.00 | 1.38M |
Jul 29
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
PharmaCyte Biotech, Inc. (PMCB) Snapshot price: $2.1702
Chief Financial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 20
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||